Heavy-Atom-Free BODIPY Dendrimer: Utilizing the Spin-Vibronic Coupling Mechanism for Two-Photon Photodynamic Therapy in Zebrafish

Lingfeng Wang,Ying Qian
DOI: https://doi.org/10.1039/d4tb00535j
IF: 7.571
2024-05-23
Journal of Materials Chemistry B
Abstract:In this paper, the heavy-atom-free BODIPY dendrimer TM4-BDP was synthesized for the near-infrared photodynamic therapy, which was composed of the triphenylamine-BODIPY dimer and four 1-(2-morpholinoethyl)-1H-indole-3-ethenyl groups. The TM4-BDP could achieve the near-infrared photodynamic therapy through two different photosensitive pathway, which include the one-photon excitation at 660 nm and two-photon excitation at 1000 nm. In the one-photon excitation pathway, the TM4-BDP could generate singlet oxygen and superoxide radical under 660 nm illumination. In addition, the one-photon PDT experiment in human nasopharyngeal carcinoma (CNE-2) cells also indicated that the TM4-BDP could specific accumulate in lysosomes and shown great cell phototoxicity with the IC50 at 22.1μM. In the two-photon excitation pathway, the two-photon absorption cross section at 1030 nm of TM4-BDP was determined as 383 GM, which make it could generate the reactive oxygen species (ROS) under 1000 nm femtosecond laser excitation. Moreover, the two-photon PDT experiment in zebrafish also indicated the TM4-BDP could be used for the two-photon fluorescence imaging and the two-photon induced ROS generation in biological environment. Besides that, in the ROS generation mechanism aspect, the TM4-BDP employ the novel spin-vibronic coupling intersystem crossing (SV-ISC) process for the mechanism of ROS generation and the femtosecond transient absorption spectra indicated that this novel SV-ISC mechanism was closely related with its' lifetime of charge transfer state. These above experiments of TM4-BDP demonstrate that the dendrimer design was an effective strategy for constructing heavy-atom-free NIR BODIPY photosensitizers and lay the foundation for the two-photon photodynamic therapy in the future clinical trails.
materials science, biomaterials
What problem does this paper attempt to address?